NIH and FDA leaders call for innovation in development of smoking cessation treatments

Niaid.nih.gov

Click here to subscribe to Niaid.nih.gov

1 month ago

Html
Text

Having trouble viewing this email? View it as a Web page.

You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).

NIH and FDA leaders call for innovation in development of smoking cessation treatments 10/15/2024 10:15 AM EDT
Commentary emphasizes that engagement across stakeholders is critical to accelerate smoking cessation and reduce smoking-related disease and death.

Update Your E-mail Address | Add Subscriptions | Unsubscribe All

If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. For all other inquiries about NIH programs and activities, please contact Ask NIH. Before writing, please view ourFrequently Asked Questions page, our Health Information page, or Search our website.

This service is provided to you by the National Institutes of Health.
NIHTurning Discovery Into Health

This email was sent to newsletter@newslettercollector.com using GovDelivery Communications Cloud on behalf of: National Institutes of Health (NIH) 9000 Rockville Pike Bethesda MD 20892 301-496-4000 / TTY 301-402-9612

Share on

Other newsletters from Niaid.nih.gov

Register to Join! NIH World AIDS Day Event Niaid.nih.gov
9 hours ago
Regstrese para unirse! Evento d el Da Mundial del SIDA de los NIH Niaid.nih.gov
9 hours ago
Newer epilepsy medications used during pregnancy do not affect neurological development in children Niaid.nih.gov
12 hours ago

More newsletters from Niaid.nih.gov

NIH and FDA leaders call for innovation in development of smoking cessation treatments

Share on

Other newsletters from Niaid.nih.gov

Related newsletters